ArticleClinical pharmacokinetics2017

CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients.

Daniel T Barratt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.